6:26 PM
Nov 29, 2012
 |  BC Extra  |  Company News

New consortium debuts to study drug-target kinetics

Bayer AG (Xetra:BAYN) and Leiden University (Leiden, the Netherlands) launched the Kinetics for Drug Discovery (K4DD) consortium to optimize a binding kinetics approach for drug discovery. The five-year consortium will focus on developing assays to evaluate target residence time...

Read the full 179 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >